19 resultados para Bis(oxazoline) ligands

em Consorci de Serveis Universitaris de Catalunya (CSUC), Spain


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Aquest article tracta el tema del “ne bis in idem” com a garantia processal penal del sistema interamericà de protecció dels drets humans. Tot fent referència als casos portats a la Cort Inteamericana de Drets Humans, s’hi presenten algunes consideracions que s’han tingut en compte a l’hora de flexibilitzar-ne el principi. Aquesta garantia es compara amb el sistema del “double jeopardy” de la common law. Així mateix, es compara també amb altres sistemes de protecció dels drets humans, com l’europeu, el del Tribunal Penal Internacional i el del Pacte de Drets Civils i Polítics de les Nacions Unides. Per concloure, es destaca la importància de l’harmonització de les garanties del procés penal en relació amb la discussió de conflictes jurisdiccionals. Aquest text és fruit de les reflexions debatudes Durand el curs de postgrau de la Facultat de Dret de la Universitat de São Paulo, “As Garantias do Processo Penal no Sistema Interamericano de Direitos Humanos”, 2008.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Este artículo trata el tema del ne bis in idem como garantía procesal penal dentro del sistema interamericano de protección de los derechos humanos. Haciendo referencia a los casos llevados ante la Corte Interamericana de Derechos Humanos, se presentan algunas reflexiones que fueron tomadas en consideración para la flexibilización del principio. Esta garantía se compara con el sistema del “double jeopardy” de la common law. Asimismo, se compara también con otros sistemas de protección de los derechos humanos, como el europeo, el del Tribunal Penal Internacional y el del Pacto de Derechos Civiles y Políticos de las Naciones Unidas. Finalmente, se destaca la importancia de la armonización de garantías del proceso penal en la discusión de conflictos jurisdiccionales. Este texto es producto de las reflexiones debatidas en el curso de postgrado de la Facultad de Derecho de la Universidad de São Paulo, “As Garantias do Processo Penal no Sistema Interamericano de Direitos Humanos”, 2008.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

En aquest treball s’ha plantejat estudiar la capacitat de diferents bissulfonamides per promoure, actuant com a àcids Brønsted, l’addició estereoselectiva d’un grup al·lil o un indole a un catió acilimini. Per això, s’han sintetitzat diversos tipus de bis-sulfonamides amb simetria C2, en forma enantiopura, i preparat precursors genèrics de cations N-acilimini. S’han dut a terme reaccions d’al·lilació i d’addició d’indole en diferents condicions i amb les diferents sulfonamides. Es va estudiar la possible estereoselectivitat dels productes d’addició, però en cap cas la presència de les bis-sulfonamides sintetitzades en la reacció ha afectat a l’estereoselectivitat de les addicions.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The synthesis of three bidentate, hemilabile phosphine ligands, newly synthesized in the research group (TPOdiphos, DPPrPOdiphos and SODPdiphos), has been up-scaled and optimized. The ligand substitution reaction on Mo(CO)6 and W(CO)6 has been studied and the corresponding complexes fac-[MTPOdiphos(CO)3], fac-[MDPPrPOdiphos(CO)3], and fac-[MSODPdiphos(CO)3], (M= Mo, W) have been isolated in good yields and characterized by NMR, IR and HR MS. In the case of fac- [MoTPOdiphos(CO)3] the XRD crystal structure was resolved. The complexes were found to be octahedral, neutral molecules, with the metal in the zero oxidation state and the ligand adopting a facial P,P,O-coordination. The hard ligand atom (oxygen) is expected to exhibit special features the future applications of these novel ligands.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

El legislador estatal ha introduït un nou article 200 bis a la LCSP, amb la finalitat de lluitar contra la morositat de les Administracions públiques. No obstant això, com es veurà al llarg del present Treball sota l’enunciat de: “Procediment per fer efectius els deutes de les administracions publiques”, amaga simplement la regulació d’una nova mesura cautelar i la reducció del termini per aquests supòsits d’inactivitat administrativa. Per analitzar adequadament el contingut d’aquest article, hem considerat oportú estudiar les mesures cautelars en lo contenciós-administratiu. El camí recorregut comença en els antecedents jurisprudencials en l’aplicació de l’anterior normativa en mesures cautelars, segueix per la regulació comunitària i cóm aquesta va ser aplicada en un conegut cas del TJCE – cas Factortame-, això ens permetrà entendre el gir jurisprudencial del Tribunal Suprem de 1990 així com el alè donat pel Tribunal Constitucional. Tot això, ens conduirà al anàlisi dels articles 129, 130 i 136 de la vigent Llei de la jurisdicció contenciós-administratiu, això ens porta finalment al anàlisis del 200 bis.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Projecte de recerca elaborat a partir d’una estada a la University of British Columbia, Canadà, entre 2010 i 2012 La malaltia d'Alzheimer (MA) representa avui la forma més comuna de demència en la població envellida. Malgrat fa 100 anys que va ser descoberta, encara avui no existeix cap tractament preventiu i/o curatiu ni cap agent de diagnòstic que permeti valorar quantitativament l'evolució d'aquesta malaltia. L'objectiu en el que s'emmarca aquest treball és contribuir a aportar solucions al problema de la manca d'agents terapèutics i de diagnosi, unívocs i rigorosos, per a la MA. Des del camp de la química bioinorgànica és fàcil fixar-se en l'excessiva concentració d'ions Zn(II) i Cu(II) en els cervells de malalts de MA, plantejar-se la seva utilització com a dianes terapèutica i, en conseqüència, cercar agents quelants que evitin la formació de plaques senils o contribueixin a la seva dissolució. Si bé aquest va ser el punt de partida d’aquest projecte, els múltiples factors implicats en la patogènesi de la MA fan que el clàssic paradigma d’ ¨una molècula, una diana¨ limiti la capacitat de la molècula de combatre aquesta malaltia tan complexa. Per tant, un esforç considerable s’ha dedicat al disseny d’agentsmultifuncionals que combatin els múltiples factors que caracteritzen el desenvolupament de la MA. En el present treball s’han dissenyat agents multifuncionals inspirats en dos esquelets moleculars ben establers i coneguts en el camp de la química medicinal: la tioflavina-T (ThT) i la deferiprona (DFP). La utilització de tècniques in silico que inclouen càlculs farmacocinètics i modelatge molecular ha estat un procés cabdal per a l’avaluació dels millors candidats en base als següents requeriments: (a) compliment de determinades propietats farmacocinètiques que estableixin el seu possible ús com a fàrmac (b) hidrofobicitat adequada per travessar la BBB i (c) interacció amb el pèptid Aen solució.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

A series of new benzolactam derivatives was synthesized and the derivatives were evaluated for theiraffinities at the dopamine D1, D2, and D3 receptors. Some of these compounds showed high D2 and/orD3 affinity and selectivity over the D1 receptor. The SAR study of these compounds revealed structuralcharacteristics that decisively influenced their D2 and D3 affinities. Structural models of the complexesbetween some of the most representative compounds of this series and the D2 and D3 receptors wereobtained with the aim of rationalizing the observed experimental results. Moreover, selected compoundsshowed moderate binding affinity on 5-HT2A which could contribute to reducing the occurrence of extrapyramidalside effects as potential antipsychotics.

Relevância:

20.00% 20.00%

Publicador:

Relevância:

20.00% 20.00%

Publicador:

Resumo:

We describe the use of dynamic combinatorial chemistry (DCC) to identify ligands for the stem-loop structure located at the exon 10-5'-intron junction of Tau pre-mRNA, which is involved in the onset of several tauopathies including frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17). A series of ligands that combine the small aminoglycoside neamine and heteroaromatic moieties (azaquinolone and two acridines) have been identified by using DCC. These compounds effectively bind the stem-loop RNA target (the concentration required for 50% RNA response (EC(50)): 2-58 μM), as determined by fluorescence titration experiments. Importantly, most of them are able to stabilize both the wild-type and the +3 and +14 mutated sequences associated with the development of FTDP-17 without producing a significant change in the overall structure of the RNA (as analyzed by circular dichroism (CD) spectroscopy), which is a key factor for recognition by the splicing regulatory machinery. A good correlation has been found between the affinity of the ligands for the target and their ability to stabilize the RNA secondary structure.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

We describe the effect of guanidinylation of the aminoglycoside moiety on acridine-neamine-containing ligands for the stem-loop structure located at the exon 10-5′-intron junction of Tau pre-mRNA, an important regulatory element of tau gene alternative splicing. On the basis of dynamic combinatorial chemistry experiments, ligands that combine guanidinoneamine and two different acridines were synthesized and their RNA-binding properties were compared with those of their amino precursors. Fluorescence titration experiments and UV-monitored melting curves revealed that guanidinylation has a positive effect both on the binding affinity and specificity of the ligands for the stemloop RNA, as well as on the stabilization of all RNA sequences evaluated, particularly some mutated sequences associated with the development of FTDP-17 tauopathy. However, this correlation between binding affinity and stabilization due to guanidinylation was only found in ligands containing a longer spacer between the acridine and guanidinoneamine moieties, since a shorter spacer produced the opposite effect (e.g. lower binding affinity and lower stabilization). Furthermore, spectroscopic studies suggest that ligand binding does not significantly change the overall RNA structure upon binding (circular dichroism) and that the acridine moiety might intercalate near the bulged region of the stem->loop structure (UV-Vis and NMR spectroscopy).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Intrinsic resistance to the epidermal growth factor receptor (EGFR; HER1) tyrosine kinase inhibitor (TKI) gefitinib, and more generally to EGFR TKIs, is a common phenomenon in breast cancer. The availability of molecular criteria for predicting sensitivity to EGFR-TKIs is, therefore, the most relevant issue for their correct use and for planning future research. Though it appears that in non-small-cell lung cancer (NSCLC) response to gefitinib is directly related to the occurrence of specific mutations in the EGFR TK domain, breast cancer patients cannot be selected for treatment with gefitinib on the same basis as such EGFR mutations have beenreported neither in primary breast carcinomas nor in several breast cancer cell lines. Alternatively, there is a generalagreement on the hypothesis that the occurrence of molecular alterations that activate transduction pathways downstreamof EGFR (i.e., MEK1/MEK2 - ERK1/2 MAPK and PI-3'K - AKT growth/survival signaling cascades) significantly affect the response to EGFR TKIs in breast carcinomas. However,there are no studies so far addressing a role of EGF-related ligands as intrinsic breast cancer cell modulators of EGFR TKIefficacy. We recently monitored gene expression profiles andsub-cellular localization of HER-1/-2/-3/-4 related ligands (i.e., EGF, amphiregulin, transforming growth factor-α, ß-cellulin,epiregulin and neuregulins) prior to and after gefitinib treatment in a panel of human breast cancer cell lines. First, gefitinibinduced changes in the endogenous levels of EGF-related ligands correlated with the natural degree of breast cancer cellsensitivity to gefitinib. While breast cancer cells intrinsically resistant to gefitinib (IC50 ≥15 μM) markedly up-regulated(up to 600 times) the expression of genes codifying for HERspecific ligands, a significant down-regulation (up to 106 times)of HER ligand gene transcription was found in breast cancer cells intrinsically sensitive to gefitinib (IC50 ≤1 μM). Second,loss of HER1 function differentially regulated the nuclear trafficking of HER-related ligands. While gefitinib treatment induced an active import and nuclear accumulation of the HER ligand NRG in intrinsically gefitinib-resistant breastcancer cells, an active export and nuclear loss of NRG was observed in intrinsically gefitinib-sensitive breast cancer cells.In summary, through in vitro and pharmacodynamic studies we have learned that, besides mutations in the HER1 gene,oncogenic changes downstream of HER1 are the key players regulating gefitinib efficacy in breast cancer cells. It now appears that pharmacological inhibition of HER1 functionalso leads to striking changes in both the gene expression and the nucleo-cytoplasmic trafficking of HER-specific ligands,and that this response correlates with the intrinsic degree of breast cancer sensitivity to the EGFR TKI gefitinib. Therelevance of this previously unrecognized intracrine feedback to gefitinib warrants further studies as cancer cells could bypassthe antiproliferative effects of HER1-targeted therapeutics without a need for the overexpression and/or activation of other HER family members and/or the activation of HER-driven downstream signaling cascades

Relevância:

20.00% 20.00%

Publicador:

Resumo:

El artículo analiza los elementos esenciales del nuevo delito de trata de personas que incorporado al CP mediante la reforma de 2010. Asimismo explora la tipificación de la trata de personas en Derecho comparado, los compromisos internacionales adquiridos por el Estado español acerca de la incriminación de esta conducta y su nivel de cumplimiento con el nuevo delito.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The study of the reactivity of three 1-(2-dimethylaminoethyl)-1H-pyrazole derivatives of general formula [1-(CH2)2NMe2}-3,5-R2-pzol] {where pzol represents pyrazole and Rdouble bond; length as m-dashH (1a), Me (1b) or Ph (1c)} with [MCl2(DMSO)2] (Mdouble bond; length as m-dashPt or Pd) under different experimental conditions allowed us to isolate and characterize cis-[M{κ2-N,N′-{[1-(CH2)2NMe2}-3,5-R2-pzol])}Cl2] {MMdouble bond; length as m-dashPtPt (2a-2c) or Pd (3a-3c)} and two cyclometallated complexes [M{κ3-C,N,N′-{[1-(CH2)2NMe2}-3-(C5H4)-5-Ph-pzol])}Cl] {Mdouble bond; length as m-dashPt(II) (4c) or Pd(II) (5c)}. Compounds 4c and 5c arise from the orthometallation of the 3-phenyl ring of ligand 1c. Complex 2a has been further characterized by X-ray crystallography. Ligands and complexes were evaluated for their in vitro antimalarial against Plasmodium falciparum and cytotoxic activities against lung (A549) and breast (MDA MB231 and MCF7) cancer cellular lines. Complexes 2a-2c and 5c exhibited only moderate antimalarial activities against two P. falciparum strains (3D7 and W2). Interestingly, cytotoxicity assays revealed that the platinacycle 4c exhibits a higher toxicity than cisplatin in the three human cell lines and that the complex 2a presents a remarkable cytotoxicity and selectivity in lung (IC50 = 3 μM) versus breast cancer cell lines (IC50 > 20 μM). Thus, complexes 2c and 4c appear to be promising leads, creating a novel family of anticancer agents. Electrophoretic DNA migration studies in presence of the synthesized compounds have been performed, in order to get further insights into their mechanism of action.